propranolol has been researched along with cardiovascular agents in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (43.28) | 18.7374 |
1990's | 8 (11.94) | 18.2507 |
2000's | 11 (16.42) | 29.6817 |
2010's | 18 (26.87) | 24.3611 |
2020's | 1 (1.49) | 2.80 |
Authors | Studies |
---|---|
Gerber, JG; Nies, AS | 1 |
Boudoulas, H; Leier, CV; Lewis, RP; Rittgers, SE; Weissler, AM | 1 |
Evenou, JP; Hof, A; Hof, RP; Novosel, D | 1 |
Dahlöf, C; Dimenäs, E; Olofsson, B | 1 |
Greenblatt, DJ | 1 |
Preobrazhenskiĭ, DV | 1 |
Arakawa, K; Hiroki, T; Kumagai, S; Moriyama, Y; Mutaguchi, T; Shindo, M; Tanaka, H; Yoshida, T | 1 |
Krumpl, G; Raberger, G; Schneider, W; Winkler, M | 1 |
Degoutrie, G; Kaltenbach, M; Landgraf, H; Schräder, R | 1 |
Gross, GJ; Kampine, JP; Riley, DC; Warltier, DC | 1 |
Krumpl, G; Raberger, G; Schneider, W | 1 |
McGuirk, SM; Muir, WW | 1 |
Al'perovich, BR; Kukes, VG; Rumiantsev, AS | 1 |
Hageman, GR; James, TN; Neely, BH; Urthaler, F | 1 |
Bochkareva, EV; Kokurina, EV; Martsevich, SIu; Shakarova, SSh; Vygodin, VA | 1 |
Block, HU; Förster, W; Giessler, C; Heinroth, I; Mentz, P; Pönicke, K; Rettkowski, W; Zehl, U | 1 |
Chen, YH; Huang, TC; Jiang, WD; Liu, WW; Wang, YP; Yu, YZ | 1 |
Giessler, C; Mentz, P; Pawelski, KE | 1 |
Broustet, JP; Colle, JP; Hilaire, J; Theron, M | 1 |
Harron, DW; Nicholls, DP; Shanks, RG | 1 |
Vlietstra, RE | 1 |
Kaplan, HR; Smith, RD; Tessman, DK | 1 |
McAnulty, JH; Metcalfe, J; Ueland, FR; Ueland, K | 1 |
Drake, CE | 1 |
Zeng, GY; Zhang, LY; Zhang, Y; Zhou, YP | 1 |
Affrime, MB; Lowenthal, DT | 1 |
Allen, EW; Basmadjian, G; Hinkle, G; Ice, R; Waschek, J | 1 |
Balakumaran, K; Simoons, ML | 1 |
Sanchez-Cascos, A | 1 |
Ashour, F; Hazzaa, AA; Shafik, RM | 1 |
Mentzer, RM; Moss, RL; Strang, KT | 1 |
Johnson, IR; Rouse, W; Stafford, PJ | 1 |
Eichler, HG; Kastner, J; Krejcy, K; Schmetterer, L; Unfried, C; Wolzt, M; Zanaschka, G | 1 |
Blaufarb, I; Frishman, WH; Pfeifer, TM | 1 |
Church, DB; Watson, AD | 1 |
Cornell, ES; Heckbert, SR; Psaty, BM; Smith, NL; Tracy, RP | 1 |
Casadei, B; Hogan, N; Paterson, DJ | 1 |
Fukui, Y; Hayase, T; Yamamoto, K; Yamamoto, Y | 1 |
Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
Hashimoto, K; Saegusa, Y; Satoh, Y; Sugiyama, A; Takahara, A; Yoneyama, M | 1 |
Kogaki, S; Kurotobi, S; Nasuno, S; Ohta, M; Okabe, H; Ozono, K; Sakai, N; Takahashi, K; Taniike, M; Wada, K | 1 |
Compagnon, P; Iacob, M; Joannides, R; Lerebours, G; Menard, JF; Moore, N; Thuillez, C | 1 |
Hartshorn, EA | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
Akiyama, Y; Nozawa, H; Sunaga, S; Tsurita, G | 1 |
Fastbom, J; Johnell, K | 1 |
Imura, S; Ozden, I | 1 |
Cho, KW; Choi, DH; Choi, HR; Cui, HZ; Kang, DG; Lee, HS | 1 |
Giest, H; Graffstaedt, H; Meyer, L; Truebenbach, J; Waner, M | 1 |
Chary, NS; Lin, AY; Lin, CA; Tung, HH | 1 |
Dean, P; Marshall, S; Ruddy, JP | 1 |
Halloran, C; Monteiro, R; Samuels, TL; Uncles, DR; Willers, JW | 1 |
Assar, AN | 1 |
Engberg Damsgaard, T; Vandborg Bjerre, J | 1 |
Barrufet, M; Cardenas, A; Escorsell, A; Garcia-Pagán, JC | 1 |
Guan, J; Pan, W; Pan, Y; Qu, X; Zhang, L; Zhang, W; Zhu, Z | 1 |
Patanè, S | 1 |
Feng, H; Kauvar, ANB | 1 |
Armelin, VA; Braga, VHDS; Florindo, LH; Lopes, IG | 1 |
Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
Bui, AD; Eisenmann, ED; Heikkila, ME; Huntley, MR; Johnson, BL; Rorabaugh, BR; Rose, RM; Seeley, SL; Zoladz, PR | 1 |
Casas, G; Francisco-Pascual, J; García-Dorado, D; Moya-Mitjans, À; Rivas-Gándara, N | 1 |
Apra, C; Bourdillon, P; Dumot, C; Pelissou-Guyotat, I | 1 |
Agarwal, R; Chen, CS; Chopra, A; Cicconet, M; Ewoldt, J; Garfinkel, AC; Mücke, M; Neyazi, M; Pourquié, O; Rao, J; Schmid, M; Seidman, CE; Seidman, JG; Sharma, A; Toepfer, CN; Willcox, JAL | 1 |
Chang, L; Chang, SJ; Gao, W; Jin, Y; Lin, X; Ma, G; Qiao, C; Qiu, Y | 1 |
Kondratenko, SN; Kovachevich, IV; Kukes, VG; Polyakov, AV; Repenkova, LG; Savelyeva, MI; Svistunov, AA | 1 |
10 review(s) available for propranolol and cardiovascular agents
Article | Year |
---|---|
Disposition of cardiovascular drugs in the elderly.
Topics: Aged; Aging; Cardiovascular Agents; Humans; Propranolol | 1989 |
[Effect of antianginal, hypotensive and diuretic agents on blood lipid composition].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Cardiovascular Agents; Diuretics; Drug Therapy, Combination; Humans; Lipids; Lipoproteins; Propranolol | 1986 |
Pharmacokinetics of cardiovascular drugs.
Topics: Biological Availability; Cardiovascular Agents; Digoxin; Half-Life; Heart Diseases; Humans; Kinetics; Lidocaine; Models, Biological; Procainamide; Propranolol; Quinidine | 1980 |
Special considerations in the use of cardiovascular drugs.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiac Glycosides; Cardiovascular Agents; Disopyramide; Diuretics; Female; Fetus; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide; Propranolol; Quinidine | 1981 |
beta-blockers. Drug interactions of clinical significance.
Topics: Adrenergic beta-Antagonists; Anesthetics; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cardiovascular Agents; Drug Interactions; Propranolol | 1995 |
Interactions of cardiac drugs.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digitalis Glycosides; Drug Interactions; Humans; Procainamide; Propranolol; Quinidine | 2006 |
Medical treatment of small abdominal aortic aneurysm.
Topics: Aortic Aneurysm, Abdominal; Cardiovascular Agents; Disease Progression; Doxycycline; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indomethacin; Propranolol; Risk Factors; Risk Reduction Behavior; Roxithromycin; Time Factors; Treatment Outcome | 2012 |
Management of gastric varices.
Topics: Anti-Bacterial Agents; Balloon Occlusion; Cardiovascular Agents; Cyanoacrylates; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Tissue Adhesives | 2014 |
Ebola: is there a hope from treatment with cardiovascular drugs?
Topics: Cardiovascular Agents; Hemorrhagic Fever, Ebola; Humans; Propranolol; Treatment Outcome; Vascular Endothelial Growth Factor A | 2014 |
Could propranolol be beneficial in adult cerebral cavernous malformations?
Topics: Adrenergic beta-Antagonists; Brain Neoplasms; Cardiovascular Agents; Hemangioma, Cavernous, Central Nervous System; Humans; Propranolol | 2019 |
8 trial(s) available for propranolol and cardiovascular agents
Article | Year |
---|---|
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.
Topics: Administration, Oral; Adolescent; Adult; Cardiovascular Agents; Clinical Trials as Topic; Coronary Circulation; Deslanoside; Diastole; Dobutamine; Heart Rate; Humans; Infusions, Parenteral; Injections, Intravenous; Isoproterenol; Lidocaine; Male; Myocardial Contraction; Propranolol; Time Factors | 1979 |
Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.
Topics: Brain; Cardiovascular Agents; Double-Blind Method; Humans; Oxazepam; Propranolol; Reproducibility of Results; Surveys and Questionnaires | 1989 |
[Treatment of hyperkinetic heart syndrome with alinidine and propranolol].
Topics: Adult; Blood Pressure; Cardiovascular Agents; Clonidine; Echocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Neurocirculatory Asthenia; Propranolol | 1987 |
[Ergometric evaluation of corinfar, phenoptin, obsidan and 2% nitroglycerin ointment in exercise-induced stenocardia].
Topics: Adult; Angina Pectoris; Cardiovascular Agents; Clinical Trials as Topic; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Ointments; Propranolol; Vasodilator Agents; Verapamil | 1985 |
Cardiovascular effects of AQ-A 39 in healthy volunteers.
Topics: Adult; Blood Pressure; Cardiovascular Agents; Cardiovascular System; Heart Rate; Humans; Isoindoles; Male; Phthalimides; Physical Exertion; Propranolol | 1983 |
Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.
Topics: Adult; Blood Pressure; Cardiovascular Agents; Clonidine; Heart Rate; Humans; Hydralazine; Male; Posture; Propranolol | 1983 |
Short-term drug effects on the signal-averaged electrocardiogram in healthy men: assessment of intra- and interindividual variability of spectral temporal mapping and time-domain analysis.
Topics: Adenosine; Adult; Atropine; Cardiovascular Agents; Cross-Over Studies; Electrocardiography; Heart; Hemodynamics; Humans; Isoproterenol; Lidocaine; Male; Norepinephrine; Placebos; Propranolol; Reference Values; Reproducibility of Results; Time Factors; Verapamil | 1995 |
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Benzazepines; Cardiovascular Agents; Cross-Over Studies; Depression, Chemical; Double-Blind Method; Epinephrine; Exercise; Heart Rate; Hemodynamics; Humans; Ivabradine; Male; Norepinephrine; Propranolol; Rest; Tilt-Table Test | 2006 |
49 other study(ies) available for propranolol and cardiovascular agents
Article | Year |
---|---|
Abrupt withdrawal of cardiovascular drugs.
Topics: Cardiovascular Agents; Clonidine; Hemodynamics; Homeostasis; Humans; Nitroglycerin; Nitroprusside; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome; Sympathetic Nervous System | 1979 |
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart Failure; Heart Rate; Milrinone; Myocardial Contraction; Nitroprusside; Ouabain; Propranolol; Pyridones; Rabbits; Vagotomy; Vasodilator Agents | 1992 |
Effect of nifedipine, dilazep, dinitrates and propranolol on blood lactate accumulation during intensive graded exercise testing in healthy young subjects.
Topics: Adult; Blood Pressure; Cardiovascular Agents; Dilazep; Exercise Test; Heart Rate; Humans; Lactates; Lactic Acid; Nifedipine; Nitrates; Propranolol | 1988 |
Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
Topics: Animals; Benzazepines; Blood Pressure; Cardiac Output; Cardiovascular Agents; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Physical Exertion; Propranolol; Stroke Volume | 1988 |
Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs.
Topics: Anesthesia, Inhalation; Animals; Benzazepines; Cardiovascular Agents; Dogs; Electrocardiography; Female; Heart Rate; Hemodynamics; Isoflurane; Male; Propranolol | 1987 |
Can exercise-induced regional contractile dysfunction be prevented by selective bradycardic agents?
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Clonidine; Dogs; Hemodynamics; Male; Myocardial Contraction; Physical Exertion; Propranolol | 1986 |
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Drug Administration Schedule; Edema; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Horse Diseases; Horses; Injections, Intravenous; Lidocaine; Procainamide; Propranolol; Quinidine | 1985 |
Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction.
Topics: Acetylcholine; Animals; Atrioventricular Node; Atropine; Cardiac Pacing, Artificial; Cardiovascular Agents; Clonidine; Depression, Chemical; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Male; Norepinephrine; Parasympathetic Nervous System; Parasympatholytics; Premedication; Propranolol; Sinoatrial Node; Stellate Ganglion; Time Factors; Vagus Nerve | 1985 |
[Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
Topics: Angina Pectoris; Cardiovascular Agents; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Physical Endurance; Propranolol | 1985 |
Influence of cardiovascular drugs on platelet aggregation.
Topics: Animals; Cardiovascular Agents; Dipyridamole; Epoprostenol; Humans; Myocardium; Nitroglycerin; Nitroprusside; Nonachlazine; Platelet Aggregation; Propranolol; Rabbits; Rats; Trapidil | 1983 |
[Effects of sodium tanshinone II-A sulfonate and propranolol on coronary collaterals in acutely infarcted dogs (author's transl)].
Topics: Animals; Cardiovascular Agents; Collateral Circulation; Coronary Circulation; Dogs; Furans; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Phenanthrenes; Propranolol | 1981 |
Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Cardiovascular Agents; Dipyridamole; Guinea Pigs; Heart; Heart Atria; Myocardial Contraction; Propranolol; Prostaglandin Endoperoxides, Synthetic; Trapidil; Verapamil | 1984 |
Acute tolerance to prazosin in conscious hypertensive rats: involvement of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Captopril; Cardiovascular Agents; Clonidine; Dose-Response Relationship, Drug; Drug Tolerance; Hydrochlorothiazide; Hypertension; Indomethacin; Male; Methyltyrosines; Prazosin; Propranolol; Quinazolines; Rats; Renin | 1981 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; Disopyramide; Humans; Hypotension; Lidocaine; Liver; Phenytoin; Procainamide; Propranolol; Quinidine; Vasodilator Agents | 1982 |
[Effects of tetramethylpyrazine on cardiac haemodynamics in dogs (author's transl)].
Topics: Animals; Cardiovascular Agents; Dogs; Hemodynamics; Oxygen Consumption; Propranolol; Pyrazines; Reserpine | 1982 |
Cardiovascular drugs for the geriatric patient.
Topics: Aged; Aging; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Digoxin; Disopyramide; Humans; Intestinal Absorption; Kidney; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Effect of cardiac drugs on imaging studies with thallous chloride Tl 201.
Topics: Adult; Aged; Cardiovascular Agents; Heart; Humans; Middle Aged; Propranolol; Radioisotopes; Radionuclide Imaging; Thallium | 1981 |
The effects of drugs on the exercise electrocardiogram.
Topics: Cardiovascular Agents; Clonidine; Double-Blind Method; Electrocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Propranolol; Vasodilator Agents; Verapamil | 1981 |
Evaluation of effect of drugs on the exercise ECG.
Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil | 1981 |
Synthesis of 1,2,4-triazolythiopropanolamines as potential cardiovascular agents.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Cats; Heart Rate; Hemodynamics; Propanolamines; Propranolol | 1980 |
Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of beta-adrenergic stimulation.
Topics: Adenosine; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Cardiovascular Agents; Female; Heart Rate; Isometric Contraction; Isoproterenol; Muscle Proteins; Myocardial Contraction; Myocardium; Phosphorylation; Propranolol; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Sarcomeres | 1995 |
The haemodynamic actions of ZENECA ZD7288, a novel sino-atrial node function modulator, in the exercising beagle: a comparison with zatebradine and propranolol.
Topics: Animals; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dogs; Heart Rate; Hemodynamics; Physical Conditioning, Animal; Propranolol; Pyrimidines; Sinoatrial Node | 1994 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular Agents; Cat Diseases; Cats; Digoxin; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Diseases; Heart Failure; Lidocaine; Propranolol; Surveys and Questionnaires; Vasodilator Agents | 1995 |
The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly.
Topics: Aged; Aspirin; Cardiovascular Agents; Digoxin; Humans; Hydrochlorothiazide; Patient Compliance; Propranolol; Reproducibility of Results | 1999 |
Nitric oxide donors can increase heart rate independent of autonomic activation.
Topics: Adrenergic beta-Antagonists; Animals; Autonomic Nervous System; Baroreflex; Cardiovascular Agents; Heart Rate; In Vitro Techniques; Male; Molsidomine; Nitric Oxide Donors; Nitroprusside; Propranolol; Pyrimidines; Rabbits; Sympathectomy; Vagotomy; Vasodilator Agents | 1999 |
Comparison of effect of ethanol and anticonvulsants on cardiovascular drug-modified cocaine toxicity.
Topics: Animals; Anticonvulsants; Cardiovascular Agents; Cocaine; Diazepam; Enalapril; Ethanol; Male; Mice; Mice, Inbred ICR; Phenobarbital; Phentolamine; Propranolol; Seizures | 2000 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
Cardiac effects of clinically available Kampo medicine assessed with canine isolated, blood-perfused heart preparations.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Blood Transfusion; Cardiovascular Agents; Cell Membrane; Cross Circulation; Dogs; Heart; Heart Ventricles; Homeostasis; In Vitro Techniques; Medicine, Kampo; Myocardial Contraction; Myocardium; Perfusion; Propranolol; Sinoatrial Node; Subcellular Fractions | 2002 |
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Chromosomes, Human, Pair 12; Drug Therapy, Combination; Glutamic Acid; Glutamine; Humans; Imidazoles; Infant; Intracellular Signaling Peptides and Proteins; Male; Mutation, Missense; Noonan Syndrome; Propranolol; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Treatment Outcome | 2005 |
A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Cardiovascular Agents; Cimetidine; Corticotropin-Releasing Hormone; Heart Rate; Histamine H1 Antagonists; Histamine H2 Antagonists; Male; Muscarinic Antagonists; Peptide Fragments; Propranolol; Pyrilamine; Rats; Rats, Sprague-Dawley; Urocortins | 2007 |
Ischemic colitis following colonoscopy in an elderly patient on cardiovascular medication.
Topics: Aged, 80 and over; Arrhythmias, Cardiac; Cardiovascular Agents; Colitis, Ischemic; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Digoxin; Drug Therapy, Combination; Female; Humans; Hypertension; Intestinal Mucosa; Nicardipine; Postoperative Complications; Propranolol; Risk Factors; Sigmoid Neoplasms | 2007 |
The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cardiovascular Agents; Cross-Sectional Studies; Depression; Drug Utilization; Female; Humans; Logistic Models; Male; Propranolol; Registries | 2008 |
Somatostatin and propranolol for the treatment of small-for-size syndrome after liver transplantation.
Topics: Cardiovascular Agents; Humans; Liver Diseases; Liver Transplantation; Living Donors; Organ Size; Propranolol; Somatostatin; Syndrome | 2008 |
Aqueous extract of Zanthoxylum schinifolium elicits contractile and secretory responses via beta1-adrenoceptor activation in beating rabbit atria.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Cardiotonic Agents; Cardiovascular Agents; Cyclic AMP; Diltiazem; Heart Atria; Hemodynamics; Imidazoles; Plant Extracts; Plant Leaves; Plant Stems; Propanolamines; Propranolol; Pyrroles; Rabbits; Receptors, Adrenergic, beta-1; Stroke Volume; Zanthoxylum | 2009 |
Effectiveness of propranolol in a newborn with liver hemangiomatosis.
Topics: Cardiovascular Agents; Female; Hemangioma; Humans; Infant; Liver Neoplasms; Propranolol | 2010 |
Potential for biodegradation and sorption of acetaminophen, caffeine, propranolol and acebutolol in lab-scale aqueous environments.
Topics: Acebutolol; Acetaminophen; Adsorption; Biodegradation, Environmental; Caffeine; Cardiovascular Agents; Central Nervous System Stimulants; Clinical Laboratory Techniques; Environmental Restoration and Remediation; Propranolol; Sensory System Agents; Water Pollutants, Chemical | 2010 |
Intravenous lipid emulsion in propranolol [corrected] overdose.
Topics: Adult; Cardiovascular Agents; Drug Overdose; Electrocardiography; Fat Emulsions, Intravenous; Female; Humans; Propranolol | 2010 |
Logging the potential for intravenous lipid emulsion in propranolol and other lipophilic drug overdoses.
Topics: Cardiovascular Agents; Drug Overdose; Fat Emulsions, Intravenous; Humans; Propranolol | 2011 |
Haemangioma and propranolol.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Combined Modality Therapy; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Magnetic Resonance Imaging; Propranolol | 2014 |
In vitro and in vivo evaluations of a novel pulsed and controlled osmotic pump capsule.
Topics: Animals; Capsules; Cardiovascular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dogs; Drug Chronotherapy; Drug Delivery Systems; Glycerol; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Models, Biological; Osmosis; Phthalic Acids; Propranolol | 2015 |
Successful Treatment of a Residual, Thick, Infantile Hemangioma in a Darker Phototype Pediatric Patient Using the 755-nm Long-Pulsed Alexandrite Laser.
Topics: Cardiovascular Agents; Child, Preschool; Female; Hemangioma, Capillary; Humans; Lasers, Gas; Lasers, Solid-State; Low-Level Light Therapy; Propranolol | 2017 |
The influence of midazolam on heart rate arises from cardiac autonomic tones alterations in Burmese pythons, Python molurus.
Topics: Animals; Atropine; Autonomic Nervous System; Boidae; Bradycardia; Cardiovascular Agents; Electrocardiography; GABA Modulators; Heart; Heart Rate; Hypnotics and Sedatives; Midazolam; Propranolol | 2017 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Myocardial hypersensitivity to ischemic injury is not reversed by clonidine or propranolol in a predator-based rat model of posttraumatic stress disorder.
Topics: Adrenergic Agents; Animals; Anxiety; Cardiovascular Agents; Clonidine; Disease Models, Animal; Disease Susceptibility; Heart; Male; Myocardial Ischemia; Myocardium; Propranolol; Random Allocation; Rats, Sprague-Dawley; Stress Disorders, Post-Traumatic; Sympathetic Nervous System; Treatment Failure | 2019 |
Postural Orthostatic Tachycardia Syndrome and Vasospastic Angina: Therapeutic Approach to a Previously Unreported Association.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Anti-Inflammatory Agents; Cardiovascular Agents; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Female; Fludrocortisone; Humans; Ivabradine; Middle Aged; Postural Orthostatic Tachycardia Syndrome; Propranolol; Tilt-Table Test | 2019 |
SarcTrack.
Topics: Algorithms; Benzylamines; Cardiovascular Agents; Carrier Proteins; Clustered Regularly Interspaced Short Palindromic Repeats; Computer-Aided Design; Fluorescence; Humans; Induced Pluripotent Stem Cells; Microscopy, Atomic Force; Myocardial Contraction; Myocytes, Cardiac; Myosins; Propranolol; Sarcomeres; Software; Uracil; Urea; Verapamil; Video Recording | 2019 |
Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
Topics: Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Drug Repositioning; Echocardiography; Gene Expression Regulation; Heart Valves; Heterozygote; Humans; Infant; MAP Kinase Kinase 1; Mutation; Natriuretic Peptide, Brain; Noonan Syndrome; Peptide Fragments; Propranolol; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; ras Proteins; Signal Transduction; Treatment Outcome | 2019 |
A 7-year follow-up study on untreated deep or mixed facial infantile hemangioma in East-Asian patients: When propranolol was not yet an option.
Topics: Asian People; Cardiovascular Agents; Child; Child, Preschool; Conservative Treatment; Disease Progression; Face; Female; Follow-Up Studies; Hemangioma; Humans; Male; Prognosis; Propranolol; Remission, Spontaneous; Retrospective Studies; Skin; Skin Neoplasms; Watchful Waiting | 2019 |
Peculiarities of Pharmacokinetics and Bioavailability of Some Cardiovascular Drugs under Conditions of Antiorthostatic Hypokinesia.
Topics: Adult; Area Under Curve; Biological Availability; Cardiovascular Agents; Half-Life; Humans; Hypokinesia; Male; Middle Aged; Phenothiazines; Propranolol; Verapamil; Weightlessness Simulation | 2020 |